HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Hachulla Selected Research

Contraindications

2/2022Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study.
10/2014Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group.
3/2012Abatacept therapy and safety management.
5/2009Abatacept therapy and safety management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Hachulla Research Topics

Disease

49Systemic Scleroderma (Systemic Sclerosis)
03/2024 - 12/2002
19Autoimmune Diseases (Autoimmune Disease)
12/2022 - 12/2002
16Interstitial Lung Diseases (Interstitial Lung Disease)
03/2024 - 06/2008
16Infections
12/2023 - 05/2008
16Vasculitis (Vasculitides)
08/2023 - 09/2011
13Fibrosis (Cirrhosis)
03/2024 - 01/2004
13Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021 - 03/2004
11COVID-19
12/2023 - 06/2021
10Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
09/2023 - 08/2006
10Rheumatoid Arthritis
08/2023 - 05/2009
10Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 06/2009
9Pulmonary Arterial Hypertension
03/2024 - 05/2008
9Connective Tissue Diseases (Connective Tissue Disease)
08/2023 - 12/2006
9Neoplasms (Cancer)
11/2021 - 05/2009
8Thrombosis (Thrombus)
09/2023 - 07/2006
8Rheumatic Diseases (Rheumatism)
03/2023 - 07/2010
8Microscopic Polyangiitis
01/2023 - 10/2006
7Inflammation (Inflammations)
12/2023 - 01/2015
7Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
11/2023 - 11/2014
7Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2023 - 10/2006
7Fatigue
11/2021 - 06/2011
6digital ulcers
10/2023 - 04/2006
6Hypertension (High Blood Pressure)
09/2023 - 01/2021
6Pulmonary Hypertension
08/2022 - 01/2004
6Antisynthetase syndrome
01/2021 - 12/2012
6Fever (Fevers)
01/2019 - 05/2006
6Pain (Aches)
01/2017 - 12/2007
5Diffuse Scleroderma (Progressive Systemic Sclerosis)
03/2024 - 01/2020
5Necrosis
09/2023 - 03/2007
5Amyloidosis
01/2023 - 12/2002
5Hemorrhage
12/2022 - 07/2006
5Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 12/2007
5Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018 - 03/2011
4Cryopyrin-Associated Periodic Syndromes
11/2022 - 05/2006
4Proteinuria
11/2022 - 12/2002
4Arthralgia (Joint Pain)
01/2022 - 05/2006
4Musculoskeletal Diseases (Musculoskeletal Disease)
01/2022 - 06/2021
4Sjogren's Syndrome (Sjogren Syndrome)
01/2020 - 06/2011
3Hypereosinophilic Syndrome (Loeffler Endocarditis)
02/2024 - 04/2019
3Bacterial Infections (Bacterial Infection)
01/2023 - 06/2014
3Familial Mediterranean Fever (Periodic Disease)
01/2023 - 06/2007
3Immunoglobulin G4-Related Disease
05/2022 - 01/2017
3Disease Progression
01/2022 - 01/2016
3Joint Diseases (Joint Disease)
01/2022 - 06/2010
3Arthritis (Polyarthritis)
07/2021 - 05/2015
3Churg-Strauss Syndrome (Allergic Angiitis)
12/2020 - 08/2015
3Mononeuropathies (Mononeuritis Multiplex)
10/2020 - 09/2004
3Capillary Leak Syndrome
05/2020 - 07/2008
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
01/2019 - 06/2010
3Castleman Disease (Castleman's Disease)
01/2019 - 01/2014
3Dermatomyositis (Dermatopolymyositis)
01/2019 - 06/2009
3Polymyositis
12/2018 - 06/2009
3Rare Diseases (Rare Disease)
01/2018 - 09/2012

Drug/Important Bio-Agent (IBA)

31AntibodiesIBA
03/2024 - 03/2004
23Rituximab (Mabthera)FDA Link
11/2023 - 01/2006
16Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2023 - 10/2006
15AutoantibodiesIBA
03/2024 - 03/2004
14Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 04/2006
11Biomarkers (Surrogate Marker)IBA
03/2024 - 12/2007
9Immunoglobulins (Immunoglobulin)IBA
05/2022 - 05/2008
9SteroidsIBA
01/2021 - 04/2005
8GlucocorticoidsIBA
03/2024 - 11/2014
8Proteins (Proteins, Gene)FDA Link
12/2023 - 12/2002
7C-Reactive ProteinIBA
04/2019 - 06/2002
7Immunoglobulin G (IgG)IBA
01/2019 - 03/2004
6Immunosuppressive Agents (Immunosuppressants)IBA
01/2022 - 11/2009
6Hydroxychloroquine (Plaquenil)FDA LinkGeneric
12/2021 - 01/2002
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2020 - 09/2004
5Intravenous Immunoglobulins (IVIG)FDA Link
12/2023 - 07/2008
5tocilizumab (atlizumab)FDA Link
01/2023 - 06/2010
5AA amyloidosisIBA
01/2023 - 05/2006
5Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
12/2022 - 08/2006
5Antirheumatic Agents (DMARD)IBA
01/2022 - 12/2017
5ametantrone (HAQ)IBA
10/2020 - 06/2015
5Carbon MonoxideIBA
01/2019 - 01/2009
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2017 - 09/2009
4EnzymesIBA
03/2024 - 07/2010
4Messenger RNA (mRNA)IBA
03/2024 - 07/2009
4Interleukin-6 (Interleukin 6)IBA
12/2023 - 01/2019
4CytokinesIBA
12/2023 - 01/2013
4InterferonsIBA
09/2023 - 05/2010
4beta-cyclodextrin tetradecasulfate (CTDS)IBA
03/2023 - 01/2011
4Antiphospholipid AntibodiesIBA
12/2022 - 01/2018
4CreatinineIBA
01/2020 - 04/2010
4Ligases (Synthetase)IBA
12/2018 - 06/2011
4Immunoglobulin M (IgM)IBA
11/2018 - 01/2013
4Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
02/2015 - 05/2006
3riociguatIBA
03/2024 - 01/2020
3VaccinesIBA
12/2023 - 06/2017
3Brain Natriuretic Peptide (Natrecor)FDA Link
07/2023 - 09/2010
3AnticoagulantsIBA
01/2023 - 07/2006
3Interleukin-1 (Interleukin 1)IBA
11/2022 - 06/2009
3Abatacept (Orencia)FDA Link
11/2022 - 05/2009
3Peroxidase (Myeloperoxidase)IBA
01/2022 - 08/2015
3Infliximab (Remicade)FDA Link
10/2020 - 01/2016
3Creatine Kinase (Creatine Phosphokinase)IBA
01/2019 - 01/2009
3Prednisone (Sone)FDA LinkGeneric
01/2018 - 01/2002

Therapy/Procedure

33Therapeutics
03/2024 - 12/2007
4Contraindications
02/2022 - 05/2009
3Aftercare (After-Treatment)
02/2022 - 01/2019